Searching for serum tumor markers for colorectal cancer using a 2-D DIGE approach (Q33487879)

27 July 2017

title

Searching for serum tumor markers for colorectal cancer using a 2-D DIGE approach (English)

1 reference

27 July 2017

1 reference

1 reference

Yanlei Ma

1

1 reference

27 July 2017

Jiayuan Peng

2

1 reference

27 July 2017

Long Huang

3

1 reference

27 July 2017

Weijie Liu

4

1 reference

27 July 2017

Peng Zhang

5

1 reference

27 July 2017

Huanlong Qin

6

1 reference

27 July 2017

publication date

1 August 2009

1 reference

27 July 2017

1 reference

27 July 2017

volume

30

1 reference

27 July 2017

issue

15

1 reference

27 July 2017

page(s)

2591-2599

1 reference

Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

The best screening test for colorectal cancer--a personal choice

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Colorectal cancer screening: scientific review

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Fecal occult blood testing for colorectal cancer. Can we afford to do this?

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Major complications of coloscopy: bleeding and perforation

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Endoscopic complications. Results of the 1974 American Society for Gastrointestinal Endoscopy Survey

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Difference gel electrophoresis. A single gel method for detecting changes in protein extracts

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Fluorescent two-dimensional difference gel electrophoresis unveils the potential of gel-based proteomics.

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Fluorescence two-dimensional difference gel electrophoresis and mass spectrometry based proteomic analysis of Escherichia coli

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Double standards in quantitative proteomics: direct comparative assessment of difference in gel electrophoresis and metabolic stable isotope labeling.

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/ MALDI-TOF/TOF and data validation by routine clinical assays

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Mining the plasma proteome for cancer biomarkers

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

A mouse to human search for plasma proteome changes associated with pancreatic tumor development

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

The human transaldolase gene (TALDO1) is located on chromosome 11 at p15.4-p15.5

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Mechanism of cancer cell adaptation to metabolic stress: proteomics identification of a novel thyroid hormone-mediated gastric carcinogenic signaling pathway

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

2D-DIGE as a strategy to identify serum markers for the progression of prostate cancer.

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Enrichment of low-abundant serum proteins by albumin/immunoglobulin G immunoaffinity depletion under partly denaturing conditions

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Glutathione Levels and Sensitivity to Apoptosis Are Regulated by Changes in Transaldolase Expression

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Thyroid hormone action in mitochondria

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Thyroid hormone induces hypoxia-inducible factor 1alpha gene expression through thyroid hormone receptor beta/retinoid x receptor alpha-dependent activation of hepatic leukemia factor

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and glycolytic genes.

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Shaping the future of biomarker research in breast cancer to ensure clinical relevance

1 reference

https://api.crossref.org/works/10.1002/ELPS.200950082

7 January 2021

Identifiers

DOI

10.1002/ELPS.200950082

1 reference

27 July 2017

1 reference